Substituted imidazo[1,5-a]pyrazines as Btk inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 7, 2018
Grant Date -
Jan 11, 2018
app pub date -
Dec 17, 2015
filing date -
Dec 31, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, Formula (I) or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully